Hims & Hers Health, Inc. (HIMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 800M 1.6B 2.4B FY24: 1.5B FY25: 2.3B FY24 FY25

Gross Profit Annual

0 600M 1.2B 1.8B FY24: 1.2B FY25: 1.7B FY24 FY25

Operating Income Annual

0 40M 80M 120M FY24: 61.9M FY25: 105.6M FY24 FY25

Net Income Annual

0 50M 100M 150M FY24: 126M FY25: 128.4M FY24 FY25

Cost of Revenue Annual

0 250M 500M 750M FY24: 303.4M FY25: 614.3M FY24 FY25

Operating Cash Flow Annual

0 150M 300M 450M FY24: 251.1M FY25: 300M FY24 FY25

Free Cash Flow Annual

0 70M 140M 210M FY24: 198.3M FY25: 57.4M FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 90M 180M 270M FY24: 236.8M FY25: 258.2M FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '24: 0.44 Q4 '24: 0.53 Q1 '25: 0.68 Q2 '25: 0.79 Q3 '25: 0.53 Q4 '25: 0.51 Q1 '26: -0.09 Q2 '26: -0.63 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.